Seegene slipped into the red in the first quarter of this year due to a drop in the number of people testing for the virus as it is shifting to an endemic phase in much of the world, company officials said Friday. The COVID-19 PCR test kit maker posted a 13.8 billion won ($10.35 million) operating loss for the first three months of 2023, while sales plunged to 90.1 billion won.
Seegene spearheading Korea s biotech drive koreatimes.co.kr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from koreatimes.co.kr Daily Mail and Mail on Sunday newspapers.
Seegene spearheading Korea s biotech drive koreatimes.co.kr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from koreatimes.co.kr Daily Mail and Mail on Sunday newspapers.